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Abstract: Dermal and transdermal drug therapy is increasing in importance nowadays in drug 
development. To completely utilize the potential of this administration route, it is necessary to 
optimize the drug release and skin penetration measurements. This review covers the most well-
known and up-to-date methods for evaluating the cutaneous penetration of drugs in vitro as a 
supporting tool for pharmaceutical research scientists in the early stage of drug development. The 
aim of this article is to present various experimental models used in dermal/transdermal research 
and summarize the novel knowledge about the main in vitro methods available to study skin 
penetration. These techniques are: Diffusion cell, skin-PAMPA, tape stripping, two-photon 
microscopy, confocal laser scanning microscopy, and confocal Raman microscopic method. 
Keywords: drug release; skin penetration; Franz cell; skin-PAMPA; tape stripping; two-photon 
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1. Introduction 
The number of dermal formulations has grown in recent decades. According to a market analysis 
conducted in 2016, profits from transdermal preparations will increase significantly by 2024 [1]. The 
basic reason for their success is that they have numerous benefits. These include, for example, non-
invasive treatment, gastrointestinal tract protection, and avoiding the first pass metabolism of the 
liver. Topical semisolid preparations are complex formulations. The physical characteristics of the 
product depend on numerous factors, including the particle size of dispersed particles, the surface 
tension between the phases, the fractional distribution of the drug between the phases, and 
rheological behavior. These attributes collectively determine the in vitro release profile, together with 
additional characteristics. The quantity of Active Pharmaceutical Ingredients (API) released in vitro 
is an essential characteristic of a product. 
Topical and transdermal formulations are commonly used for carrying drugs to the skin and the 
underlying tissue, or through the skin for systemic action. The modelling of penetration into a skin 
layer and permeation through the skin is a complex challenge. The device with the attributes of the 
formulation influence how the system can be examined the most effectively. There are several types 
of methods with which the release and penetration of drug carrier systems can be examined.  
Semisolid products, including creams, ointments, and gels are regularly well-accepted by 
patients. Topical formulations deliver the active substance into different layers of the skin, therefore, 
various diseases can be prevented and/or cured. The start, duration, and depth of the therapeutic 
effect depend on the efficacy of three consecutive processes: 1) The liberation of the API from the 
carrier system; 2) the penetration/permeation of the API into the stratum corneum (SC) or other skin 
layers; 3) the effect at the target point. All these processes determine the safety-efficacy profile of a 
product [2]. 
The investigational method is greatly influenced by the predictive ability, time, and labor 
requirements of the given method and its cost. Human skin examinations give the most appropriate 
information but, because of the high cost, it is a commonly accepted way to choose simpler methods 
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in the early stages of formulation development [3]. These investigations also help other industries in 
addition to pharmaceutical research. In agrochemistry, pesticides and insect repellents are involved, 
and the veterinary and cosmetic industries also rely on these methods [4]. 
1.1. Structure and Function of the Skin 
The skin is the largest organ of the human body and has a surface area of about 2 m2 in healthy 
grown-ups [5]. The human skin is a complex organ that acts as the first protecting barrier of the body. 
The clarification of skin structure, mainly in relation to its barrier function, has been studied by many 
researchers since the 1960s [6–10]. It is a multilayer tissue, and its main function is to guard the body 
against external circumstances by functioning as an effective barrier to the absorption of exogenous 
particles [11–13]. The skin is an important target as well as a main barrier for dermal drug delivery 
[14]. 
The skin consists of three main layers: The epidermis, the dermis, and the subcutaneous tissue. 
The epidermis, excluding the stratum corneum, which is its outside layer, is a viable tissue. The 
epidermis does not have vascularization, and nutrients diffuse from the dermo-epidermal junction 
to maintain its viability. There are five layers that describe the different steps of cell life in the 
epidermis (Figure 1) [15]. These sublayers are the following, beginning from the non-viable stratum 
corneum: Stratum lucidum (clear layer), stratum granulosum (granular layer), stratum spinosum 
(spinous or prickle layer), and stratum germinativum (basal layer). Providing mechanical protection, 
the cutaneous barrier protects the body from drying as well as from the penetration of dangerous 
substances and microorganisms. The stratum corneum acts as a critical part in the barrier function 
for topical drug penetration. Various models have been recommended for mimicking the SC. The 
most simplistic model is defined as a ‘‘brick and mortar’’ structure; the stratum corneum includes 
corneocytes (the ‘‘bricks’’) and an intercellular lipid matrix (the ‘‘mortar’’), which is essentially 
responsible for the barrier function [9]. The SC cells are named corneocytes. There are 15 to 20 layers 
of corneocytes with a thickness of 10 to 15 μm, but when hydrated, the stratum corneum considerably 
grows, and its thickness may reach up to 40 μm, showing extended permeability. These cells are 
dense, functionally dead and anucleated. The lipids form bilayers surrounding the corneocytes. The 
intercellular lipid consists of a mixture of fatty acids, ceramides, cholesterol, cholesterol esters and a 
small fraction of cholesterol sulfate [11,16,17]. Considering its barrier qualities and water resistance, 
the stratum corneum is the main layer that limits drug permeation through the skin [15]. 
 
Figure 1. Structure of the epidermis and the intercellular lipid matrix. 
There are three different pathways allowing substances to pass through the cutaneous barrier 
[18]. There are three major routes of penetration for the passive diffusion of a molecule across the SC 
(Figure 2). The first pathway is the intercellular penetration pathway, which has come to be the most 
important one for many years. Approximately 15 years ago, the follicular penetration pathway was 
also found to be a second essential pathway. The transcellular penetration pathway, where the 
materials pass through both the corneocytes and the lipid layers, seems to be unimportant at present 
[16,19]. 
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The difference between skin penetration and permeation is important. Buist and co-workers 
have defined them as follows [20]. Dermal penetration: The movement of a chemical from the outer 
surface of the skin into the epidermis, but not necessarily into the circulatory system. Dermal 
permeation: The penetration through one layer into another, which is both functionally and 
structurally different from the first layer.  
 
Figure 2. Routes of penetration. A: Intercellular penetration pathway, B: Follicular penetration 
pathway, C: Transcellular penetration pathway. 
1.2. Modifying Factors of Skin Penetration 
The interactions between the drug, skin, and vehicle determine: 1) The drug release, 2) the 
penetration through the SC, 3) the penetration through the viable skin layers.  
The liberation of an API from a pharmaceutical product applied to the skin and its transport to 
the systemic circulation is a multistep process which includes (a) the release of API from the 
preparation, (b) drug partitioning into the stratum corneum, (c) drug diffusion toward the stratum 
corneum, (d) drug partitioning from the stratum corneum into viable epidermis layers, (e) diffusion 
across the viable epidermis layers into the dermis, (f) drug absorption by vessels, (g) reaching 
systemic circulation (Figure 3). 
 
Figure 3. Drug transport across the skin. 
The selection of APIs for dermal delivery must be based on many factors, including 
physicochemical characteristics, drug interactions with the membrane, and pharmacokinetic aspects. 
The ideal physicochemical characteristics of a drug chosen for cutaneous administration are low 
reaches systemic circulation
drug absorption by vessels
diffusion across the viable epidermis layers into the dermis
drug partitioning from the stratum corneum into viable 
epidermis layers
drug diffusion toward the stratum corneum
drug partitioning into the stratum corneum
release of API from the preparation
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molecular weight (<600 Da); low melting point (<200 ℃), which is related to appropriate solubility; a 
high but stable partition coefficient because very high partition coefficients may increase drug 
retention, thus inhibiting drug clearance from the skin, and of course, solubility in water and oils to 
achieve a proper concentration gradient and increase the diffusion force over the skin [21–24]. 
Percutaneous penetration is affected by biological factors, too. There is basic variability in the 
skin barrier, due to factors such as skin hydration level, age, gender, site of the skin surface, 
malformations due to illness or damage and prior treatment [25–29]. To provide the skin with a 
healthy barrier function, the hydration level of the skin needs to be balanced, and enough volume of 
water is needed. If hydration increases, permeability may be improved [30]. Age has an impact on 
penetration into the skin. Baby skin and damaged skin have higher permeability.  
The permeability of the drug through the stratum corneum is modulated by the carrier/vehicle, 
too. A vehicle can improve the physical state and permeability of the skin by the hydration effect or 
an alteration of the lipid bilayer structure. 
1.3. General Guidelines of Skin Penetration Testing 
Recently, the regulation of dermal and transdermal preparations has received increasing 
attention. More and more documents are available for dermal absorption studies from Europe and 
the United States (Figure 4). These documents promote a harmonized road to conducting dermal and 
transdermal studies. The Organization for Economic Cooperation and Development (OECD) 
published several issues about this topic, including the Guidance Notes on Dermal Absorption (No. 
156) [20], Test Guidelines 427 (in vivo methods) [31] and 428 (in vitro methods) [32], and the Guidance 
Document for the Conduct of Skin Absorption Studies [33]. There are some other documents such as 
the World Health Organization International Programme on Chemical Safety (WHO/IPCS) 
Environmental Health Criteria 235 [34], the European Centre for Ecotoxicology and Toxicology of 
Chemicals (ECETOC) Monograph 20 [35], the United States Environmental Protection Agency 
(USEPA) report on dermal exposure assessment [36], and the European Food Safety Agency (EFSA) 
Guidance on dermal absorption for plant protection products [20,37]. These documents present rules 
on and descriptions of how to perform dermal absorption assays, however, the measurements are 
not properly regulated. There are two suggested methods. One is the widely used diffusion cell and 
the tape stripping methods. However, in the scientific literature there are a lot of other types of 
measurements, such as spectroscopic and microscopic methods, to complete the suggested tests. 
 
Figure 4. Guidelines for modelling dermal penetration/permeation. 
2. Techniques for Modelling Penetration/Permeation through Human Skin 
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There are two main types of techniques. Quantitative techniques include the use of diffusion 
cells and skin-PAMPA. Qualitative or semiquantitative techniques are different microscopic and 
spectroscopic methods and the combinations thereof. Figure 5 shows the quantitative and qualitative 
methods for following up skin penetration. 
Quantitative in vitro tests are regularly performed to measure the amount of API permeated 
through a membrane over time in relation to the diffusion area related to the collected quantity of 
API in an acceptor chamber [11,38–43]. In the case of qualitative techniques, the aim is usually to 
follow the active substance. The presence or the relative amount of the active ingredient in the 
different skin layers can be determined. The use of multiple methods together can perfectly 
complement each other, making the regulatory authorization process easier. 
 
Figure 5. The main quantitative and qualitative methods for following up skin penetration. 
2.1. Diffusion Cells 
The skin can be considered as a selectively permeable biological membrane of drugs. Diffusion 
tests working with diffusion cells have become the “gold-standard” model due to the pioneering 
work of Dr. Thomas J. Franz, who developed the “Franz cell” in 1970. It determines important 
relationships between skin, API, and formulation [44–46]. The diffusion test models the method of 
medicine applied to the skin. This tool consists of a cell that holds a chamber for drug application, a 
membrane within which the drug may diffuse, and an acceptor media chamber from which samples 
may be investigated [47]. 
2.1.1. Types and Properties of Diffusion Cells 
Diffusion cells can be categorized into two main classes, static and flow-through cells. The cells 
are normally made of glass. In static cells, the donor, the membrane, and the acceptor may be placed 
either vertically, as in the popular Franz diffusion cell (Figure 6) [44], or horizontally (Figure 7) [48]. 
There are Franz cells which open from above, therefore the measurement runs on atmospheric 
pressure. However, most of the cells are closed from the top, and because of this, the pressure is 
higher, predicting higher penetration values. Nowadays, the "hand-sampler" Franz diffusion cells 
have been replaced by systems connected to an automated sampler. Sampling systems facilitate the 
work of researchers and reduce error from human sampling. 
Techniques
Quantitative
Diffusion cells
Skin-PAMPA
Tape stripping 
with HPLC
Qualitative or 
Semi-quantitative
Confocal RAMAN 
spectroscopy
Microscopic 
techniques
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Figure 6. Open (A) and closed (B) vertical Franz diffusion cells. 
 
Figure 7. Side-by-side cell (A) and flow-through cell (B). 
2.1.2. Diffusion Test Types 
In the EMA (2018) document (Draft Guideline on Quality and Equivalence of Topical Products) 
diffusion tests are grouped as follows. There are in vitro release tests (IVRT) and in vitro skin 
permeation studies (IVPT).  
In the case of IVRT, synthetic membrane (lipid-based or non-lipid based model membranes) 
should be used. The sample dose must be occluded and infinite. The IVRT study shows the release 
rate. The detected quantities are in the μg to mg range. In the case of IVPT, human skin should be 
used in unoccluded circumstances. The sample dose must be finite. The IVPT study shows the flux 
profile and the detected quantities are in the pg to ng range. In the early stages of development, IVRT 
should be used, thereafter, IVPT can be used for promising formulations [49]. The main differences 
are summarized in Table 1. 
Table 1. In vitro release tests (IVRT) and in vitro skin permeation studies (IVPT). 
IVRT IVPT 
Synthetic membrane Human skin 
Occluded dose Unoccluded dose 
Infinite dose Finite dose 
Release rate Flux profile 
μg to mg range pg to ng range 
Relative consistency Donor variability 
Every year, several papers are published involving the use of a vertical Franz diffusion cell. In 
the last four months, "Franz Diffusion” as a keyword can be found in 13 articles. The specifications 
of the publications are summarized in Table 2. Many different APIs and membranes were used. 
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Table 2. Some Franz diffusion measurements (last 4 months). 
Researcher Membrane/Skin Model Main Topic 
Jung Dae Lee et al. [50] 
full-thickness Sprague-Dawley rat 
skin 
permeability of 1-phenoxy-2-propanol in 
a shampoo and a cream 
Yanling Zhang et al. 
[51] 
heat separated human epidermis and 
full-thickness porcine ear skin; skin-
PAMPA membrane 
comparison of the Franz cell methods 
with different membranes and different 
doses to the skin-PAMPA method 
Sonia Trombino et al. 
[52] 
dialysis membranes and rabbit ear 
skin 
cyclosporin-A incorporated in SLN for 
the topical treatment of psoriasis  
Oludemi Taofiq et al. 
[53] 
pig ear skin studied mushroom ethanolic extracts 
Dina Ameen et al. [54] dermatomed human cadaver skin 
matrix –type patches for the transdermal 
delivery of galantamine for the treatment 
of Alzheimer’s disease 
Marcelle Silva-Abreu  
et al. [55] 
dialysis membrane and porcine 
mucosa (buccal, sublingual, nasal 
and intestinal) 
oral solution of pioglitazone for the 
treatment of Alzheimer’s disease 
Rattikorn 
Intarakumhaeng et al. 
[56] 
heat-separated torso split-thickness 
cadaver skin 
skin permeation of urea at finite dose 
and comparison to infinite dose 
condition 
Panonnummal Rajitha 
et al. [57] 
cellophane membrane, isolated pig 
ear skin and full-thickness pig ear 
skin 
methotrexate loaded topical 
nanoemulsion for the treatment of 
psoriasis 
Sahar Salehi et al. [58] rat buccal mucosa 
mucoadhesive buccal film containing 
rizatriptan benzoate and propranolol 
hydrochloride 
José L. Soriano-Ruiz  
et al. [59] 
nylon, cellulose and polysulfone 
membranes; porcine buccal mucosa, 
porcine sublingual, vaginal mucosa 
multiple emulsion for the topical 
application of clotrimazole 
Luciano Serpe et al. [60] porcine palatal mucosa 
permeation profiles of lidocaine and 
prilocaine across the palatal mucosa 
without bone 
Woan-Ruoh Lee  
et al. [61] 
nude mouse skin 
fractional CO2 laser effect on drug 
penetration and absorption 
Ahmed O.H. El-
Nezhawy et al. 
cellophane membrane 
amidoalkylating agent and SLNs with 
antimicrobial activity 
2.2. Skin-PAMPA 
The Parallel Artificial Membrane Permeability Assay (PAMPA) is a 96-well plate-based method 
for the fast determination of the passive membrane permeability of molecules [62]. It is a promising 
method because of its low cost and high throughput. There are different PAMPA models and one for 
skin penetration. The earlier published skin model combines silicone oil and isopropyl myristate [63]. 
Sinkó et al. have developed the skin-PAMPA method for the prediction of skin penetration in 
vitro [64]. Skin-PAMPA has been created to imitate the characteristics of the stratum corneum [25]. 
Using this new plate, the donor phase contacts the hydrated artificial membrane (approximately 60–
70 μL). This amount was ~180–200 μL using a conventional bottom plate. When examining the cross-
sectional image of the donor cell of the new plate, the amount of material that is in direct contact with 
the membrane is about 30 μL. This results in a clear penetration surface (0.3 cm2), leading to 100 
μL/cm2 of donor per unit area. Compared to the OECD recommendation, this is still one order of 
magnitude higher, but it is closer to the concept of finite dose [69]. Skin-PAMPA membrane was 
produced by using cholesterol, free fatty acid, and a ceramide-analogue compound that imitates the 
features of lipid matrix [65]. The donor plate of the conventional skin-PAMPA procedure requires 
the use of a large amount of sample, which does not meet the concept of finite dose. The experimental 
design is shown in Figure 8. 
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In the past few years, skin-PAMPA as a bio-relevant artificial membrane-based permeability 
model has been used for the evaluation of skin penetration (Table 3) [66]. 
 
Figure 8. Experimental design of the skin-PAMPA method. 
Table 3. Posters and articles related to the skin-PAMPA method [66]. 
Researcher Year Main Topic 
Lee et al. [67] 2010 • homogenous and normalized permeability data for more than 
40 compounds 
Tsinman et al. [68] 2012 
• investigation of ibuprofen penetration using both the skin-
PAMPA model and real human skin mounted in a Franz cell 
system 
Karadzovska and 
Riviere [69] 
2013 
• study of 96-well-based skin penetration models, including skin-
PAMPA as well, besides another PAMPA skin model by 
Ottaviani and Strat-M membrane 
Vizserálek et al. 
[70] 
2013 • the effect of incubation temperature on permeability 
Clough et al. [71] 2013 
• the permeability enhancing effect of a series of solvents, lipidic 
fluids and emulsifiers was investigated 
Luo et al. [72] 2014 
• comparison of skin-PAMPA results to porcine skin results 
measured with the Franz cell method 
2.3. The Most Important Experimental Considerations in the Case of Quantitative Methods 
In order to obtain reliable dermal permeability data, several parameters have to be considered 
for the design of the test system, which are influenced by the solubility of the compounds: 
• the sink condition 
• the incubation time 
• the incubation temperature 
• the mixing 
• the hydration of the membrane 
• the amount of dose [73]. 
In the case of molecules with low solubility, it is not so easy to create the sink condition. Ueda 
and colleagues have determined the sink condition: To achieve sink conditions, the receptor medium 
must have a relatively high capacity to dissolve or carry away the drug and the receptor media should 
not exceed 10% of drug solubility in the releasing matrix at the end of the test [74]. By changing the 
composition and the pH of the acceptor and donor phases, the suitable sink condition can be created. 
This means that under certain experimental conditions, the backflow from the acceptor phase can be 
considered as zero. Alternatively, the sink condition can be achieved by the use of surfactants in the 
acceptor phase. A further solution is the use of serum albumin because it is capable of binding 
lipophilic components, thereby keeping the free concentration of the molecule lower. The advantage 
of using albumin is that it is a sufficiently large molecule to not permeate through the skin. 
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In the case of the incubation time, it is important to consider the fact that the structure of the skin 
or the artificial membrane remains unchanged until the end of the experiment. To avoid the 
overestimation of dermal penetration, different skin integrity tests are needed to eliminate the use of 
damaged skin preparations. This test should ensure the exclusive use of skin-derived data with an 
appropriate barrier function in the assays. Several methods can be used to examine skin integrity. 
Each has advantages and disadvantages. Widely used methods are the measurement of tritium water 
permeability, the measurement of transepidermal water loss, and the determination of 
transepidermal electrical resistance. A relatively new method is the use of the tritium-labeled internal 
reference standard, where integrity testing is performed simultaneously with the measurement [60–
66]. For each method, it can be stated that the measurements are different and not properly regulated. 
Different labs use different limits and measure under different conditions. In the future, the proper 
regulation of integrity testing and the clear definition of limit values for the proper evaluation of 
dermal formulations will be essential. 
The incubation temperature affects both the permeability of the compounds and the rheological 
properties of the product studied. The selected mixing speed should guarantee enough mixing of the 
acceptor phase during the test [74]. Hydration of the skin affects, among other things, the barrier 
function of the stratum corneum, therefore, the creation of an optimal hydration state is essential [75]. 
Depending on the amount of sample in the test cells, two types of experiments can be 
distinguished: Finite and infinite dose measurements. In the case of the infinite dose, the amount of 
sample used is in large excess, hence the donor phase (the sample itself) cannot empty under normal 
circumstances. As a result, when examining a permeability-time profile in this case, the straight line 
usually rises with a constant slope without experiencing a plateau phase. The opposite of the infinite 
dose is the finite dose. When finite doses are used, a limited amount of sample (donor phase) is 
applied to the skin or to the surface of the artificial membrane. It should be noted that the latter 
experimental circumstance is much closer to the condition when the patient applies a given 
preparation onto his or her own skin. Based on the recommendation of the OECD (Organization for 
Economic Co-Operation and Development), a finite dose for a solution-phase sample is 
recommended if the applied dose does not exceed 10 μL/cm2 or is in the range of 1 to 10 mg/cm2 for 
a semisolid sample [75]. Certainly, it is more advantageous to design the measurement conditions to 
approach the finite dose requirements as much as possible [64]. 
There are some measurement parameters which affect drug penetration, such as occlusive or 
non-occlusive application [76,77]. Dermal and transdermal drug delivery can be performed after 
occlusive or non-occlusive (open) application. Occlusion can be achieved by covering the skin by 
impermeable films or others, such as strips, gloves, diapers, textiles garments, wound dressings or 
transdermal therapeutic systems [78]. 
2.4. Tape Stripping 
The quantification of APIs within the skin is crucial for topical and transdermal delivery 
examinations. Nowadays, horizontal sectioning, consisting of tape completely stripping the stratum 
corneum, has become one of the conventional investigation procedures [79]. The method may be 
quantitative or semiquantitative depending on the analysis. 
Tape stripping is a commonly used, minimally invasive method for testing the penetration of 
topically applied formulations through the stratum corneum, whereby layers of the stratum corneum 
are removed by an adhesive tape and skin layers residing on the adhesive tape are examined (Figure 
9). On the one hand, the protein content of the different layers can be determined by the method, and 
on the other hand—after the topical application of the composition to be tested—the amount of the 
active ingredient in the selected layer can be determined. In addition to drug penetration testing, the 
effect of the substance on skin hydration and skin proteins can be observed, e.g. to modify the 
secondary structure of keratin. Tape stripping can also be used in vitro and in vivo on human and 
animal skin, as well as on appropriate skin models [15,25,80]. The Organization for Economic Co-
operation and Development Test Guideline (OECD TG) 427 describes the use of tape stripping for 
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the removal of upper skin layers and the in vivo penetration of active substances [31], while the OECD 
TG 428 has been performed with the in vitro application of the method for experiments [32]. 
 
Figure 9. Layers of the stratum corneum are removed by an adhesive tape. 
2.4.1. Method Description 
The tape stripping process begins after the topical application of the test composition and 
waiting for an appropriate incubation time. The composition can be removed or left on the skin in 
order to provide the original amount of the composition used during the measurement. This is of 
particular importance, for example, when examining sunscreen preparations, where the active 
substance on the skin surface will exert an effect, so we need to analyze it. The adhesive tape is placed 
on the skin surface and removed, always from the same selected area. It is important that the adhesive 
tape is always flattened with the same force as the roller, which eliminates the influence of wrinkles 
and recesses on tape stripping. In addition, the speed of removal is also an important factor: The 
slower the removal of the adhesive tape, the greater the adhesion of the stratum corneum to the patch, 
thus increasing the amount of skin removed from the patch. Removed adhesive tapes will contain 
both the layers of the SC and the active ingredient of the composition used [25,81,82]. 
2.4.2. Possibility of Sample Analysis 
Several methods can be used to test the sample on the adhesive tape. The HPLC analysis 
generates a quantitative result, while the spectroscopic method yields semiquantitative results. 
During the HPLC (High-Pressure Liquid Chromatography) analysis, the test material on the adhesive 
tape is extracted by a suitable method and chromatographed. In addition, atomic absorption 
spectrometry may also be used to detect certain active substances, e.g. titanium dioxide. Furthermore, 
the active ingredients containing chromophore may also be useful for testing vitamin E [83]. 
However, the most widespread method is Attenuated Total Reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR) [83]. Spectroscopy measurements are based on the irradiation of the 
sample, vibrations, and bond angle between the atoms in it, due to absorption or scattering of the 
infrared radiation. The changes in the radiation passing through the sample are measured by plotting 
the wavelength/wavenumber to obtain the spectrum that can be analyzed by qualitative and 
quantitative information. The penetration depth is thus determined by the wavelength of the infrared 
light, the refractive index of the ATR crystal and the measured material, and the angle of reflection 
[15,25]. Tape stripping combined with ATR-FTIR spectroscopy may be suitable for detecting various 
exogenous substances in certain layers of the SC. However, the difficulty of the method is that the 
characteristic peaks of the substances to be detected are often present and overlap with skin-specific 
peaks. 
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2.4.3. Possibilities for Optimizing the Experimental Protocol 
The following options may be suitable for standardizing the experimental protocol. The 
composition should preferably be applied with a latex glove in a defined amount of time. Before 
applying, it is advisable to cut one finger of the rubber gloves and dip them into the preparation to 
fill the holes on the latex. Then the glove should be cleaned. This minimizes the amount of drug lost 
in the rubber glove, thus allowing the same quantities to be applied [84]. It is advisable that parallel 
measurements should always be carried out by the same person, as this may exclude the potential 
impact of different application techniques. The intact barrier function of the skin should be checked 
before starting the experiments. A TEWL test can be used to measure skin integrity. The intact barrier 
function, suitable for starting tape stripping experiments, indicates a TEWL value of 15–20 gm−2h−1 
[80]. It is recommended that the adhesive tape be smoothed onto the skin using a roller to eliminate 
the effects of wrinkles and recesses on the skin [82]. 
2.5. Microscopic and Spectroscopic Methods Utilised for the Percutaneous Penetration of APIs 
Microscopic techniques also give important information about the spatial distribution of the 
drug inside the different skin layers or explain the mechanism of penetration. Furthermore, these are 
not destructive in vitro techniques [85–88]. Fluorescence microscopy is a frequently used method, as 
well. The evaluation of skin treated with fluorescently labeled materials by fluorescence microscopy 
has shown that the fluorescent labeled material resided in the SC or penetrated deeper in the 
epidermis [89,90]. 
Confocal microscopy is a specialized form of standard fluorescence microscopy. It has 
developed over the last five to six decades and now it is a necessary tool for scientists. The major 
confocal techniques are two-photon microscopy (2-PFM), confocal laser scanning microscopy 
(CLSM), and the youngest, Raman microscopic methods. These methods have the possibility to image 
deeper into a three-dimensional biological sample like skin at high resolution, high speed, in in vitro 
and in vivo circumstances [15,25,91,92]. 
2.5.1. Two-Photon Microscopy Method 
Two-photon scanning fluorescence microscopy has become an important tool for imaging skin 
cells. It employs a Ti-sapphire laser excitation source. In single-photon fluorescence, the fluorescence 
photon is created when a high-energy photon is incident on the fluorophore and increases the energy 
level of one of the electrons to an excited state. In two-photon excitation, the combined energy shift 
of the two low-energy photons is enough to raise the same electron to a higher energy level. The setup 
of a two-photon microscope is quite similar to that of a confocal scanning microscope with two major 
differences. Two-photon microscopes work with a tunable Ti-sapphire high-frequency pulsed laser. 
These lasers emit red and near-infrared light in the range from 650 to 1100 nanometers. The other big 
difference is that there are no pinholes in front of the detector [93].  
The most relevant advantages of 2-PFM are that the total energy transferred to the specimen is 
much lower as compared to other techniques. Furthermore, the two-photon excitation phenomenon 
occurs only at a very small focal volume and thanks to the fluorophores, a small volume of the 
specimen is excited, which decreases the possibility of photo-bleaching and photo-damage. The skin 
samples can be studied without cryofixation and cutting. In the case of imaging of UV absorbing 
fluorophores, deep tissue imaging is possible with infrared excitation because of less scattering and 
less absorption. The limitations of a two-photon microscope include the relatively high price of the 
lasers and the fact that they require a complex cooling system. Additionally, it has a lower lateral 
resolution compared to other techniques, but in practice, the difference in their resolution is not 
significant [25,94].  
Two-photon microscopes represent a relatively young technology. There are some publications 
(Table 4) in this area [95–99], but more research is expected in this field in the near future. 
Table 4. Two-photon microscopy results. 
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Researcher Year Main Topic 
Hanson et al. 
[99] 
2002 
• two-photon fluorescence lifetime imaging of the skin stratum corneum pH 
gradient 
• the effect of active and passive mechanisms upon the origin of acidic 
microdomains within the stratum corneum 
Plasencia et al. 
[95]  
2007 
• lipid domain coexistence in a broad temperature range (including 
physiological skin temperatures) using confocal and two-photon excitation 
fluorescence microscopy 
Carrer et al. 
[98] 
2008 
• images of pig skin 
• the presence of a trans-epidermal shunt 
• the junctions between corneocyte clusters accumulate liposomes 
Batista et al. 
[97] 
2016 • all layers of the porcine cornea 
Umino et al. 
[96] 
2019 
• the effects of xylitol (a component of some skin-care products) and fructose 
on lipid dynamics in an epidermal-equivalent model at the single-cell level 
by means of two-photon microscopy 
2.5.2. Confocal Laser Scanning Microscopy Method 
Confocal laser scanning microscopy (CLSM) is a non-invasive method developed from 
fluorescence microscopy. In the last years, CLSM has been widely accepted as a device to visualize 
the fluorescent model compounds in the skin. CLSM can be used to examine the skin structure 
without cutting tissue as well as to evaluate the influences of physical and chemical enhancers on 
skin permeability. It has been used in vivo and in vitro, too. CLSM is used to diagnose general skin 
dysfunctions and to identify malignant lesions, and it can characterize keratinization and 
pigmentation disorders as well [100–102]. 
CLSM can be applied to explain the mechanism by which nanoparticulate formulations promote 
skin transport. Fluorescent markers (e.g., fluorescein, Nile red, 5-bromodeoxyuridine) may be 
incorporated in nanostructured formulations, in which they are encapsulated. The therapeutic effect 
of these formulations can be examined by CLSM to identify the penetration profiles of these 
fluorescent markers across the skin or skin appendages [15,25]. Table 5 summarizes the most 
important recent results. 
Table 5. Confocal laser scanning microscopy results. 
Researcher Year Main Topic 
Simonetti et al. [103] 1995 
• diffusion pathways across the SC of native and in vitro 
reconstructed epidermis 
Zellmer et al. [104] 1998 
• vesicles made of native human SC lipids 
• interact rapidly with phosphatidylserine liposomes 
• interact weakly with human SC lipid liposomes  
• do not interact with phosphatidylcholine (PC) liposomes 
Kuijk-Meuwissen et al. 
[105,106] 
1998 
• flexible liposomes penetrated into the skin in non-occlusive 
conditions, then after occlusive application 
Touitou et al. [107] 2001 
• the penetration of fluorescent probes into fibroblasts and nude 
mice skin 
• ethosomes promoted the penetration of all probes into the cells 
Grams et al. [108,109] 
2003 
2004 
• follicular accumulation of lipophilic dyes increased when used in 
combination of surfactant-propylene glycol 
• time-resolved diffusion of a lipophilic dye into the hair follicle of 
a fresh and unfixed piece of human scalp skin 
Alvarez-Roman et al. 
[101] 
2004 
• polystyrene nanoparticles concentrated preferentially in the 
follicular openings 
• this configuration developed in a time-dependent habit, and the 
follicular localization was favored by particles of smaller size 
Patzelt et al. [19] 2011 • the follicular penetration for nanoparticles is size-dependent 
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2.5.3. Confocal Raman Microscopic Method 
Spectroscopic methods can produce molecular information about the structure of the skin. 
Raman spectroscopy is a promising spectroscopic method based on discovering the characteristic 
vibrational energy levels of a molecule excited by a laser ray and it gives information about the 
molecular structure of tissue components without the use of fluorescent labels or chemical stains 
[110–113]. Therefore, this method is promising for discovering modifications in the structure of skin 
components. In addition, it is good for following up the penetration/permeation of APIs [114,115]. 
Nowadays, Raman microscopy is a powerful technique to properly understand skin structure and 
percutaneous drug delivery [111,116–118]. 
Traditionally, the tape stripping method is used to model the penetration into the stratum 
corneum. This method is time-consuming, semi-destructive, and difficult to reproduce, and only the 
stratum corneum can be examined. Important technical developments are custom setting and the 
confocal microscope combination. This enables chemically selective and non-destructive sample 
analysis with high spatial resolution in three dimensions and allows multiple components to be 
monitored at the same time. Confocal Raman microscopy can be used to investigate topical 
formulations for both penetration and penetration depth in vitro and in vivo [119,120]. 
Permeation through the skin can be explored by chemical mapping (Figure 10). Chemical 
mapping is one of the methods of vibration spectrometry; the suitable test apparatus is a vibration 
spectrometer (e.g., Raman) and a suitable optical unit (e.g., microscope). Raman Spectrometry is 
highly selective, with a fingerprint spectrum that allows clear molecular identification. The 
irradiating light can be focused on a very small point (~1 μm2) with a suitable microscope lens, so 
reliable chemical information can also be obtained from a microscopic area of the sample. The spatial 
distribution of the fundamental components of the sample can be determined by the spectra that 
make up the map. Chemical maps contain a huge quantity of data. Although these can be controlled 
by methods commonly used in spectroscopy, the huge amount of data can be utilized more efficiently 
by using appropriate mathematical (multivariate data analysis) techniques. Thanks to these 
advantages, the technology has enormous potential in various applications: From the analysis of the 
distribution of the physiological components of the skin and tissues through the diagnosis of 
pathological conditions to biopharmaceutical studies, such as drug penetration kinetics 
[15,25,120,121]. Table 6 summarizes the most important recent results. 
 
Figure 10. Raman chemical mapping. 
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Table 6. Confocal Raman microscopic results. 
Researcher Year Main Topic 
Zhang et al. 
[122,123] 
2007 
• the spatial distribution, time-dependent penetration of phosphorylated 
resveratrol and its transformation into the active form on stratum corneum 
and live epidermis on pigskin 
Freudiger et al. 
[124] 
2008 
• the penetration of dimethyl sulfoxide and retinoic acid in mouse skin by 
stimulated Raman scattering (SRS) technique 
• the SRS technology makes it much more sensitive and provides better 
imaging than traditional Raman techniques 
Melot et al. [125] 2009 
• the influence of penetration enhancers on the delivery of trans-retinol into 
human skin 
• the penetration enhancing effect of propylene glycol and oleic acid 
• the penetration enhancement effect of propylene glycol was easy to follow, 
and propylene glycol was also detected in the deeper layers of the skin 
Gotter et al. [126] 2010 
• confocal Raman mapping to measure the amount of dithranol penetration 
into an artificial acceptor membrane (DDC membrane) at different time 
points 
Saar et al. [127] 2011 
• the penetration of ketoprofen, ibuprofen and co-solvent propylene glycol 
into mouse skin at different time intervals by SRS 
• the advantage of this technique is that it is uniquely able to provide high-
resolution three-dimensional imaging for unlabeled molecules 
• the penetration of the drug through the epidermis and through the stratum 
corneum can be simultaneously monitored and compared; in addition, 
crystals of the API can be detected on the surface of the skin 
Franzen et al. 
[128] 
2013 
• a semisolid artificial matrix to model the optical properties of human skin 
• deep profiling of skin was performed and a mathematical algorithm was 
used to describe the modification of the Raman signal in the matrix 
• the algorithm described at the artificial matrix was successfully applied to 
human skin 
Smith et al. [119] 2015 
• the most important measurements made by confocal Raman spectroscopy 
were summarized 
Ilchenko et al. 
[116] 
2016 
• made a quantitative analysis of samples on three-dimensional Raman map 
of mouse skin 
• on the spectral map of mouse skin, the components of keratin, lipids, 
water, lactate, urea, and natural hydrating factor (NMF) have been 
identified 
• the lateral and deep distribution of the major skin components derived 
from Raman maps correlates with histological information 
Berkó et al. [115] 2018 
• semiquantitative analysis of a papaverine hydrochloride containing 
lyotropic liquid crystal system 
• the Raman correlation maps complete the other skin penetration 
measurements 
Bakonyi et al.[114] 2018 
• four types of formulation: hydrogel, oleogel, lyotropic liquid crystal and 
nanostructured lipid carrier were investigated 
• the application of Raman spectroscopy provided information about the 
spatial distribution of the API in the skin 
3. Conclusions 
The modelling of penetration into a skin layer and permeation through the skin is a complex 
challenge. Although there are many quantitative and qualitative methods for following up skin 
penetration/permeation (in vitro and in vivo), the different techniques are not fully equivalent but 
complement each other. The advantages and disadvantages of the different methods are summarized 
in Table 7. For the evaluation of drug penetration, pharmaceutical technologists must decide those 
properly suited to their examinations. The models give a possibility for rapid screening and faster 
optimization of products. The selection of the most suitable in vitro model should be based on 
availability, facility of use, cost, and the respective limitations [30]. The success of topical and 
Sci. Pharm. 2019, 87, 19 15 of 21 
 
transdermal therapy is correlated to the techniques used for the evaluation of the preparations, which 
facilitate the optimization of the skin penetration of the API so that it can reach sufficient API 
penetration at the therapeutic site.  
Table 7. Advantages and disadvantages of previously discussed methods. 
Method Advantages Disadvantages 
Franz Diffusion 
• gold-standard 
• accepted by authorities 
• quantitative 
• automated (can be) 
• synthetic and biological membranes 
• repeated dosing (open cell) 
• differences between research 
labours 
• different types of cells 
• application requires practice 
Skin-PAMPA 
• fast 
• several preparations can be tested at 
the same time 
• small space and instrument demand 
• quantitative 
• near finite quantity 
• not automated 
• sampling by hand 
• only synthetic membrane 
Tape-Stripping 
• in vitro, ex vivo, in vivo 
• minimally invasive 
• accepted by authorities 
• selected layers can be examining 
• difficult to reproduce 
• not automated 
• sampling by hand 
Microscopic and 
Spectroscopic Methods 
• high resolution 
• in vitro, ex vivo (sometimes in vivo) 
• non-invasive 
• semi-destructive 
• highly selective 
• difficult to reproduce 
• expensive lasers are needed 
• only qualitative 
• usually the measurement time is 
long 
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